Ashley Marie Nelson, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 18 | 2025 | 5716 | 1.930 |
Why?
|
Quality of Life | 27 | 2024 | 13510 | 0.970 |
Why?
|
Adaptation, Psychological | 10 | 2025 | 2666 | 0.910 |
Why?
|
Graft vs Host Disease | 3 | 2025 | 3048 | 0.860 |
Why?
|
Fatigue | 8 | 2024 | 1557 | 0.790 |
Why?
|
Thrombectomy | 4 | 2024 | 675 | 0.660 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2022 | 686 | 0.640 |
Why?
|
Pelvic Exenteration | 1 | 2018 | 22 | 0.620 |
Why?
|
Interleukin-10 | 1 | 2023 | 1183 | 0.580 |
Why?
|
Anxiety | 11 | 2024 | 4672 | 0.580 |
Why?
|
Depression | 15 | 2024 | 8231 | 0.570 |
Why?
|
Hematologic Neoplasms | 8 | 2024 | 1907 | 0.560 |
Why?
|
Vertebrobasilar Insufficiency | 3 | 2024 | 113 | 0.490 |
Why?
|
Palliative Care | 5 | 2021 | 3644 | 0.450 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 538 | 0.420 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2024 | 1106 | 0.390 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2022 | 3626 | 0.380 |
Why?
|
Caregivers | 7 | 2024 | 2308 | 0.360 |
Why?
|
Androgen Antagonists | 2 | 2017 | 1421 | 0.360 |
Why?
|
Neoplasms | 9 | 2024 | 22389 | 0.260 |
Why?
|
Registries | 4 | 2024 | 8384 | 0.240 |
Why?
|
Terminal Care | 3 | 2021 | 1772 | 0.230 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2022 | 1376 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 9442 | 0.230 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4056 | 0.230 |
Why?
|
Sleep | 2 | 2021 | 4820 | 0.220 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2024 | 138 | 0.210 |
Why?
|
Stents | 2 | 2024 | 3200 | 0.200 |
Why?
|
Qualitative Research | 3 | 2025 | 3143 | 0.200 |
Why?
|
Middle Aged | 31 | 2025 | 223737 | 0.200 |
Why?
|
Humans | 50 | 2025 | 768970 | 0.170 |
Why?
|
Aged | 21 | 2025 | 171786 | 0.170 |
Why?
|
Transplantation Conditioning | 2 | 2017 | 1601 | 0.160 |
Why?
|
Actigraphy | 2 | 2024 | 527 | 0.160 |
Why?
|
Intracranial Hemorrhages | 1 | 2024 | 811 | 0.150 |
Why?
|
Male | 28 | 2025 | 365203 | 0.150 |
Why?
|
Female | 30 | 2025 | 397515 | 0.150 |
Why?
|
Models, Biological | 1 | 2014 | 9499 | 0.150 |
Why?
|
Neurotoxicity Syndromes | 1 | 2022 | 302 | 0.150 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2022 | 702 | 0.150 |
Why?
|
Transplantation, Homologous | 4 | 2024 | 4835 | 0.150 |
Why?
|
Prostatic Neoplasms | 2 | 2017 | 11230 | 0.140 |
Why?
|
Loneliness | 1 | 2019 | 211 | 0.130 |
Why?
|
Antiemetics | 1 | 2018 | 188 | 0.130 |
Why?
|
Self Efficacy | 1 | 2020 | 643 | 0.130 |
Why?
|
Social Perception | 1 | 2019 | 433 | 0.120 |
Why?
|
Pilot Projects | 3 | 2024 | 8748 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2024 | 1386 | 0.120 |
Why?
|
Nausea | 1 | 2018 | 682 | 0.120 |
Why?
|
Motivation | 1 | 2025 | 2025 | 0.120 |
Why?
|
Hospice Care | 1 | 2021 | 679 | 0.120 |
Why?
|
Survivors | 2 | 2024 | 2383 | 0.120 |
Why?
|
Vomiting | 1 | 2018 | 655 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 2 | 2022 | 1520 | 0.110 |
Why?
|
Adult | 17 | 2025 | 223851 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2025 | 5323 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2017 | 365 | 0.110 |
Why?
|
Social Support | 2 | 2022 | 2193 | 0.110 |
Why?
|
Basilar Artery | 2 | 2024 | 207 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1830 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2023 | 3232 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2126 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1602 | 0.100 |
Why?
|
Social Stigma | 1 | 2019 | 788 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1642 | 0.100 |
Why?
|
Fear | 1 | 2020 | 1493 | 0.090 |
Why?
|
Restless Legs Syndrome | 1 | 2014 | 235 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2018 | 2744 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2015 | 597 | 0.090 |
Why?
|
Spirituality | 1 | 2014 | 430 | 0.090 |
Why?
|
Chronic Disease | 1 | 2025 | 9384 | 0.080 |
Why?
|
Needs Assessment | 1 | 2015 | 1143 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2024 | 65480 | 0.080 |
Why?
|
Family | 1 | 2020 | 3208 | 0.080 |
Why?
|
Cognition | 3 | 2022 | 7081 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7453 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 1407 | 0.070 |
Why?
|
Sexual Behavior | 1 | 2017 | 2200 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3773 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59739 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2019 | 3985 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12873 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4530 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3492 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26395 | 0.050 |
Why?
|
Young Adult | 5 | 2022 | 60131 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6611 | 0.050 |
Why?
|
Prognosis | 4 | 2024 | 30046 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11886 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1899 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6982 | 0.040 |
Why?
|
Arterial Occlusive Diseases | 1 | 2024 | 746 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10868 | 0.040 |
Why?
|
Translations | 1 | 2019 | 84 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2022 | 555 | 0.040 |
Why?
|
Treatment Failure | 1 | 2024 | 2664 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14794 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2024 | 81903 | 0.040 |
Why?
|
Affect | 1 | 2024 | 1500 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 1002 | 0.030 |
Why?
|
Death | 1 | 2021 | 683 | 0.030 |
Why?
|
Perception | 1 | 2022 | 1209 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5707 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2023 | 1422 | 0.030 |
Why?
|
Uncertainty | 1 | 2020 | 769 | 0.030 |
Why?
|
Risk Factors | 3 | 2018 | 74976 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13594 | 0.030 |
Why?
|
Nitriles | 1 | 2018 | 990 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54962 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39394 | 0.030 |
Why?
|
Sexual Partners | 1 | 2017 | 807 | 0.030 |
Why?
|
Cohort Studies | 2 | 2024 | 41808 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6346 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 533 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1890 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3908 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5100 | 0.020 |
Why?
|
Psychometrics | 1 | 2019 | 3066 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6856 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 2029 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5954 | 0.020 |
Why?
|
Internet | 1 | 2019 | 3112 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3235 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8055 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 3048 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10276 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7148 | 0.020 |
Why?
|
Psychotherapy | 1 | 2014 | 1654 | 0.010 |
Why?
|
Child | 2 | 2022 | 80960 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5375 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8749 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20245 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18435 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22296 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15879 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 30265 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15951 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13698 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10847 | 0.010 |
Why?
|